Front-end manufacturing in U.S. way forward to counter tariff impact on pharma: Natco Pharma CEO
Getting a front-end manufacturing foothold in the U.S. appears to be the way out for India’s generic drugmakers in the event of U.S. levying tariff on pharmaceuticals, a top executive…